Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
1.280
-0.090 (-6.57%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Tango Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-130.3-101.74-108.18-58.24-51.97
Upgrade
Depreciation & Amortization
2.52.421.610.90.72
Upgrade
Loss (Gain) From Sale of Investments
-4.62-3.39---
Upgrade
Stock-Based Compensation
28.919.0814.237.831.76
Upgrade
Other Operating Activities
3.773.631.751.320.89
Upgrade
Change in Accounts Receivable
-2---2
Upgrade
Change in Accounts Payable
-1.18-1.711.11.231.17
Upgrade
Change in Unearned Revenue
-29.97-31.53-16.86-12.04119.08
Upgrade
Change in Other Net Operating Assets
-0.59-6.73-2.73-0.540.42
Upgrade
Operating Cash Flow
-131.5-117.98-109.08-59.5370.07
Upgrade
Capital Expenditures
-0.75-1.53-7.69-1.84-1.11
Upgrade
Investment in Securities
86.8842.9534.09-181.6-144.32
Upgrade
Other Investing Activities
-----0.04
Upgrade
Investing Cash Flow
86.1341.4326.4-183.43-145.47
Upgrade
Issuance of Common Stock
47.6682.651.621.060.04
Upgrade
Other Financing Activities
--0.24-0.01326.28-
Upgrade
Financing Cash Flow
47.6682.411.62357.3380.88
Upgrade
Net Cash Flow
2.295.85-81.07114.365.49
Upgrade
Free Cash Flow
-132.26-119.51-116.77-61.3668.97
Upgrade
Free Cash Flow Margin
-314.38%-327.18%-469.72%-165.66%900.84%
Upgrade
Free Cash Flow Per Share
-1.21-1.26-1.33-0.992.16
Upgrade
Levered Free Cash Flow
-67.27-61.82-48.74-34.02-18.57
Upgrade
Unlevered Free Cash Flow
-67.27-61.82-48.74-34.02-18.57
Upgrade
Change in Net Working Capital
6.9110.43-12.534.54-12.68
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q